Clot-Removal procedure may offer hope for severe brain stem strokes

NCT ID NCT07672795

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This trial investigates whether a procedure to remove a blood clot from the basilar artery—a major vessel at the back of the brain—can improve recovery in people with severe stroke. Participants are adults aged 18 to 80 who have a large area of brain damage and can be treated within 24 hours of symptoms. Half receive the clot-removal procedure plus standard medical care, while the other half receive standard care alone. The study measures how many people achieve a good functional outcome after 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Endovascular therapy (mechanical thrombectomy)

What this could lead to

If successful, this could expand treatment options for severe stroke patients who currently have few alternatives, potentially reducing death and disability.

What could go wrong

This is a mid-stage trial with 256 participants, so results may not apply to all patients. The procedure carries risks like bleeding or vessel damage, and may not improve outcomes over standard care alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basilar artery occlusion ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••